Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Surrogate Marker of Rate Control in Patients With Atrial Fibrillation

NCT04513509 is registered in ClinicalTrials.gov with National Taiwan University Hospital as lead sponsor.

NCT NCT04513509
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04513509 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Surrogate Marker of Rate Control in Patients With Atrial Fibrillation
Lead sponsor
National Taiwan University Hospital
Phase
Not applicable
Overall status
Completed
Start date
October 21, 2020
Completion date
July 1, 2022
Enrollment
13 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation, cardiopulmonary exercise test, rate control